Mukku V R
J Biol Chem. 1984 May 25;259(10):6543-7.
The binding of iodinated epidermal growth factor (125I-EGF) to membrane preparations from the livers of euthyroid and hypothyroid rats was examined to determine if thyroid hormones regulate EGF receptors. Binding in membrane preparations from hypothyroid livers was only 30-40% compared to that of euthyroid controls. Treatment of hypothyroid animals with a single dose of L-T3 96 h prior to sacrifice restored EGF binding nearly to the control levels. Scatchard analysis of the binding data indicated that the decrease in EGF binding in hypothyroid membranes was due to a decrease in the number of the receptors. Affinity labeling/cross-linking of 125I-EGF to hepatic membranes with disuccinimidyl suberate followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed a prominent band of Mr = 170,000, which was decreased in hypothyroid samples to the same extent as EGF binding. EGF-stimulated receptor kinase activity in detergent extracts of hepatic membranes also revealed a major phosphorylated protein species of Mr = 170,000, which was also decreased in samples from hypothyroid animals to approximately the same degree as EGF binding. Binding, affinity labeling/cross-linking, and phosphorylation measurements thus indicate that the levels of hepatic EGF receptor are regulated by thyroid status. These results raise the possibility that some in vivo affects of thyroid hormones may be mediated by alterations in EGF receptor levels.
研究了碘化表皮生长因子(125I-EGF)与正常甲状腺和甲状腺功能减退大鼠肝脏膜制剂的结合情况,以确定甲状腺激素是否调节EGF受体。与正常甲状腺对照组相比,甲状腺功能减退肝脏膜制剂中的结合仅为30%-40%。在处死前96小时用单剂量L-T3治疗甲状腺功能减退动物,可使EGF结合几乎恢复到对照水平。对结合数据的Scatchard分析表明,甲状腺功能减退膜中EGF结合的减少是由于受体数量的减少。用辛二酸二琥珀酰亚胺酯将125I-EGF与肝细胞膜进行亲和标记/交联,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和放射自显影,显示出一条突出的Mr = 170,000条带,在甲状腺功能减退样品中该条带与EGF结合减少的程度相同。肝细胞膜去污剂提取物中EGF刺激的受体激酶活性也显示出一种主要的Mr = 170,000磷酸化蛋白,在甲状腺功能减退动物的样品中该蛋白也减少到与EGF结合大致相同的程度。因此,结合、亲和标记/交联和磷酸化测量表明,肝脏EGF受体水平受甲状腺状态调节。这些结果增加了甲状腺激素的一些体内作用可能由EGF受体水平改变介导的可能性。